ProfileGDS4459 / ENSG00000126088
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 85% 76% 87% 85% 85% 82% 89% 87% 85% 87% 76% 90% 85% 79% 88% 82% 75% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 16.4785
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 25.5676
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 36.9687
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 46.3485
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 56.6285
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 66.3282
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 77.2389
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 86.8987
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 96.7785
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 106.987
GSM623474group B, liver allograft wedge biopsie placebo treatment 15.7176
GSM623475group B, liver allograft wedge biopsie placebo treatment 27.3690
GSM623476group B, liver allograft wedge biopsie placebo treatment 36.6185
GSM623477group B, liver allograft wedge biopsie placebo treatment 45.8179
GSM623478group B, liver allograft wedge biopsie placebo treatment 57.1388
GSM623479group B, liver allograft wedge biopsie placebo treatment 66.0982
GSM623480group B, liver allograft wedge biopsie placebo treatment 75.5475